A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab
Immunotherapy is an effective new approach in the treatment of many malignancies. However, pancreatic ductal adenocarcinoma (PDAC) does not usually respond to immunotherapy. We discuss the case of a patient with metastatic microsatellite instability-high PDAC who had a prolonged response to single-a...
Main Authors: | Annie A. Guedikian, Megan E. Randall, Anita Sharko, William T. Leslie |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-09-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/519181 |
Similar Items
-
Microsatellite instability in prostate cancer by PCR or next-generation sequencing
by: Jennifer A. Hempelmann, et al.
Published: (2018-04-01) -
Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer
by: Mehrdad Zeinalian, et al.
Published: (2018-01-01) -
A Preliminary Study of Microsatellite Instability Analysis in Different Genotypes of P53 Codon 72 in Breast Invasive Ductal Carcinomas
by: Mansour Salehi, et al.
Published: (2009-08-01) -
Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients
by: Angelika Copija, et al.
Published: (2017-01-01) -
Gynecological Cancers Caused by Deficient Mismatch Repair and Microsatellite Instability
by: Madhura Deshpande, et al.
Published: (2020-11-01)